Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
vx-702
vx-702
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-444 | 25mg | 123.00 | + Add to cart |
|
| R-C-444 | 100mg | 466.00 | + Add to cart |
|
| R-C-444 | 200mg | 844.00 | + Add to cart |
|
|
|
||||
Product description
VX-702 inhibits p38 MAPK, preventing p38 MAPK-dependent inflammatory cytokine release.VX-702 is in development to treat inflammation and cardiovascular diseases and currentlyshows mixed results in clinical trials as a potential treatment for rheumatoid arthritis.In vitro,Vx-702 decreases platelet lesioning in storage without affecting platelet function.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| CAS | 479543-46-9 |
| PDI by GPC | <1.5 |
| Solubility | Organic solvents |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---vx-702 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
